Mark Dainty’s Post

View profile for Mark Dainty

Lead PM @ BlueBox Precision Medicine Fund | Making biotech easy for investors to understand | PM squared - Precision Medicine x Portfolio Manager

Busy week at the Jefferies London Global Healthcare Conference....it concluded with a great panel with Peter Marks from the FDA who highlighted 1) Plans to get rare disease therapies approved more quickly, with bi-partisan support. 2) A willingness to discuss vaccine safety with the public & new government, because "the data is very clear" and a public discussion might iron out some concerns 3) Not too much worry about staff turnover at the agency Met some new (and familiar) investors and a lot of companies! Thanks to Jefferies for another great event 👏

  • No alternative text description for this image
Andrea Bici, CPA

Seeking to Re-Enter Workforce. Strong Healthcare Investing, Finance, Strategy Corporate Access Background Looking to Leverage Vast Network & Problem Solving Skills

3mo

The Jefferies conference is becoming the J.P. Morgan Memorial of the UK / EU.

Like
Reply

To view or add a comment, sign in

Explore topics